Shanmugalakshmi S, Dheenadhayalan V, Muthuveeralakshmi P, Arivarignan G, Pitchappan R M
Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai 625021, India.
Infect Immun. 2003 Aug;71(8):4544-53. doi: 10.1128/IAI.71.8.4544-4553.2003.
Purified protein derivative (PPD) RT23-recalled T-cell receptor (TCR) V beta expression was studied in the peripheral blood of 42 pulmonary tuberculosis patients and 44 healthy controls from southern India, a region where tuberculosis is endemic. Forty-eight-hour whole-blood cultures in the presence or absence of PPD-RT23 were set up, and at the end of the culture period total RNA was extracted and cDNA was synthesized. Expression of various TCR V beta families was assessed by using family-specific primers. PPD-specific expression (usage) of TCR V beta families 4, 6, 8 to 12, and 14 was found in more controls than patients. Among the responders (individuals who showed PPD-specific expression), endemic controls had significantly higher responses than the patients had for TCR V beta families 2, 3, 7, 13, and 17. The majority of the patients did not show usage of most of the TCR V beta families, and this was attributed to T-cell downregulation. A four-way nested classification analysis revealed that TCR V beta family 1, 5, 9, 12, and 13 usage in the context of HLA class II high-risk alleles (DRB11501, DRB108, and DQB1*0601) and Mycobacterium bovis BCG scar status were the determining factors in susceptibility and resistance to tuberculosis. The healthier status of controls was attributed to the wider usage of many TCR V beta families readily recalled by PPD, while the disease status of the patients was attributed to TCR V beta downregulation and the resultant T-cell (memory cell?) unresponsiveness. Host genetics (HLA status) and BCG vaccination (scar status) seem to play important roles in skewing the immune response in adult susceptibility to pulmonary tuberculosis through TCR V beta usage.
在印度南部(结核病流行地区)的42例肺结核患者和44名健康对照者的外周血中,研究了纯化蛋白衍生物(PPD)RT23召回的T细胞受体(TCR)Vβ表达。建立了在有或无PPD-RT23情况下的48小时全血培养,培养期结束时提取总RNA并合成cDNA。使用家族特异性引物评估各种TCR Vβ家族的表达。发现与患者相比,更多的对照者中存在TCR Vβ家族4、6、8至12和14的PPD特异性表达(使用情况)。在反应者(表现出PPD特异性表达的个体)中,地方性对照者对TCR Vβ家族2、3、7、13和17的反应明显高于患者。大多数患者未表现出大多数TCR Vβ家族的使用情况,这归因于T细胞下调。四向嵌套分类分析显示,在HLA II类高危等位基因(DRB11501、DRB'108和DQB1*0601)和牛分枝杆菌卡介苗疤痕状态的背景下,TCR Vβ家族1、5、9、12和13的使用情况是结核病易感性和抗性的决定因素。对照者更健康的状态归因于PPD容易召回的许多TCR Vβ家族的更广泛使用,而患者的疾病状态归因于TCR Vβ下调以及由此产生的T细胞(记忆细胞?)无反应性。宿主遗传学(HLA状态)和卡介苗接种(疤痕状态)似乎通过TCR Vβ的使用在成人肺结核易感性的免疫反应偏倚中起重要作用。